Drugs / 23-valent polysaccharide vaccine
23-valent polysaccharide vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00164411 | Jan 2004 → Mar 2005 | pneumococcal infection | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 23-valent polysaccharide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00164411 ↗ |
| Known as | Pneumococcal Polysaccharide Vaccine | “Pneumococcal Polysaccharide Vaccine (23-valent)” NCT00164411 ↗ |
| Known as | PPV23 | “The only vaccine licensed in the United States for protecting adults against pneumococcal disease (PPV23) protects against invasive disease in observational studies but has...” NCT00164411 ↗ |
| Modality | Vaccine | “The only vaccine licensed in the United States for protecting adults against pneumococcal disease (PPV23) protects against invasive disease in observational studies but has...” NCT00164411 ↗ |